Susan Romanus
No más puestos en curso
Fortuna: 196 971 $ al 31/05/2024
Perfil
Susan Romanus worked as a Senior Director & Compliance Officer at Merck Vaccine Division.
She then worked as Vice President, Chief Ethics & Compliance Officer at Daiichi Sankyo Co., Ltd.
Later, she worked as Chief Compliance & Quality Officer at ADC Therapeutics SA. Finally, she worked as Vice President-Compliance at Taiho Oncology, Inc. Ms. Romanus completed her undergraduate degree from the University of California San Diego and her MBA from the University of San Diego.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0.06% | 01/02/2023 | 57 426 ( 0.06% ) | 196 971 $ | 31/05/2024 |
Antiguos cargos conocidos de Susan Romanus.
| Empresas | Cargo | Fin |
|---|---|---|
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Oficial de Cumplimiento | 01/01/2018 |
| DAIICHI SANKYO CO., LTD. | Oficial de Cumplimiento | 01/01/2012 |
| Merck Vaccine Division | Oficial de Cumplimiento | - |
| ADC THERAPEUTICS SA | Oficial de Cumplimiento | - |
Formación de Susan Romanus.
| University of California San Diego | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Empresas privadas | 2 |
|---|---|
| Merck Vaccine Division | |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Susan Romanus
